Clinical Teaching definition

Clinical Teaching means off-campus health science teaching involving client care.
Sample 1Sample 2Sample 3
Clinical Teaching means off-campus health science teaching involving client care. "Duty'' refers to any time when an academic staff member is required by Wintec to be on duty at the campus or at another location.
Sample 1
Clinical Teaching means any suitable supervised clinical, practical or other learning experience offered to students in a workplace environment, provided, conducted or arranged by the Placement Provider which usually includes but is not limited to, an NHS Trust, NHS Foundation Trust, GP surgery or other organisations that form part of the National Health Service or that deliver placement learning funded by the NHS which for the purposes of the NHS Education Contract includes the private, independent and voluntary organisations (PIVO).
Sample 1

Examples of Clinical Teaching in a sentence

  • This Agreement is informed by, but not limited to, the following frameworks, policies, guidelines and plans: • WA Disability Health Framework 2015-2025 • Clinical Health Services Framework 2014-2024 • Purchasing and Resource Allocation Policy Framework • Performance Policy Framework • Outcome Based Management Policy Framework • Clinical Governance, Safety and Quality Policy Framework • Research Policy Framework • Clinical Teaching and Training Policy Framework • ICT Policy Framework.

  • This Agreement is informed by, but not limited to, the following frameworks, policies, guidelines and plans:  WA Disability Health Framework 2015-2025  Clinical Health Services Framework 2014-2024  Purchasing and Resource Allocation Policy Framework  Performance Policy Framework  Outcome Based Management Policy Framework  Clinical Governance, Safety and Quality Policy Framework  Research Policy Framework  Clinical Teaching and Training Policy Framework  ICT Policy Framework.

  • Yes Family Medicine SOGH Family Med Surgery Yes Family Medicine SOGH Clinical Teaching Unit Yes Genetics HSC Genetics / Genetics Yes Genetics HSC/ST.

  • I have read the Memorandum of Understanding and the Clinical Teaching Handbook and I will adhere to the requirements identified therein.

  • Other postings on your social media sites (i.e. Facebook, Twitter, Instagram) deemed inappropriate or unprofessional can lead to a disqualification hearing and removal from the Clinical Teaching Semester.

  • Clinical Teaching candidates will follow the adopted lesson plan format.

  • An 3 eligible preceptor shall be defined as a nurse who has completed the Division of 4 Nursing Preceptor Education Program and who has been assigned by the manager to 5 act either (1) as a preceptor to new RN hires, RNs participating in internship programs 6 or student nurses, or (2) as a Clinical Teaching Associate for an immersion student.

  • If commitments become problematic in terms of attendance and performance, the candidate will be given the choice of withdrawing from their Clinical Teaching Semester or making the personal adjustments necessary to give full attention to the program.

  • Candidates should refrain from posting comments about their Clinical Teaching Semester, pictures of MTs, students or events at their placement school.

  • The Clinical Teaching Semester is not an observation experience; it is a hands-on, actively participating experience.

Related to Clinical Teaching

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Research Program has the meaning set forth in Section 2.1.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Clinical peer means a physician or other health care professional who holds a non-restricted license in a state of the United States and in the same or similar specialty as typically manages the medical condition, procedure or treatment under review.

  • Student teaching means a supervised teaching practice occurring near the end of an applicant's approved program.

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.